CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection	hepatocellular carcinoma	Recruiting	Phase 1	2024-08-19		NCT06560827

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CARsgen Therapeutics Co., Ltd.	20
Shanghai Zhongshan Hospital	347

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Hospital Chinese Academy of Medical Sciences	Beijing	China	33
Chongqing university ca cer hospital	Chongqing	China	1
Hunan Provincial People's Hospital	Changsha	China	4
Liaoning Cancer Hospital	Shenyang	China	14
Mengchao Hepatobiliary Hospital of Fujian Medical University	Fuzhou	China	4
Sichuan Cancer Hospital	Chengdu	China	21
Sir Run Run Shaw Hospital Zhejiang University School of Medicine	Hangzhou	China	5
Sun Yat-sen University Cancer Center	Guanzhou	China	2
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	61
The First Hospital of China Medical University	Shenyang	China	22
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	18
Tianjin medical university cancer hospital	Tianjin	China	1
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology	Wuhan	China	4
West China Hospital of Sichuan University	Chengdu	China	30
ZhongShan Hospital Fudan University	Shanghai	China	22